You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pemetrexed

Showing 51 - 75 of 527
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

Recruiting
  • Nonsquamous Non-Small Cell Lung Cancer
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Nov 5, 2021

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Pemetrexed
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

DLBCL Trial in Seoul (Tislelizumab, Pemetrexed)

Not yet recruiting
  • DLBCL
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 15, 2022

NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Telisotuzumab Vedotin
  • +4 more
  • (no location specified)
Oct 17, 2023

NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Mar 23, 2023

Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

Terminated
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 3, 2022

Non-squamous NSCLC Trial (biological, drug, dietary supplement)

Not yet recruiting
  • Non-squamous NSCLC
  • Pembrolizumab
  • +7 more
  • (no location specified)
Feb 20, 2023

Stage IV Lung Adenocarcinoma Trial in United States (Certolizumab, cisplatin, pemetrexed)

Completed
  • Stage IV Lung Adenocarcinoma
  • Basking Ridge, New Jersey
  • +5 more
Jan 25, 2023

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

NSCLC Trial in Tampa, Philadelphia (Durvalumab, Carboplatin, Abequolixron)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tampa, Florida
  • +1 more
Jun 9, 2023

Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

Not yet recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • (no location specified)
Jul 7, 2023

Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Locally Advanced
  • Non-small Cell Lung Cancer
  • Shanghai, China
    Shanghai Pulmonary Hospital
Mar 14, 2023

NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Wuhan, Hubei, China
    Qian Chu
Aug 18, 2023

Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

Completed
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • Basel, Switzerland
  • +3 more
Jul 13, 2021

Advanced Cancer, Metastatic Cervical Cancer Trial in Albuquerque, Yerevan (Balstilimab (BAL), Topotecan, Vinorelbine)

Withdrawn
  • Advanced Cancer
  • Metastatic Cervical Cancer
  • Balstilimab (BAL)
  • +5 more
  • Albuquerque, New Mexico
  • +2 more
Oct 3, 2022

Tumors Trial (vibostolimab, pembrolizumab, pemetrexed)

Active, not recruiting
  • Neoplasms
  • vibostolimab
  • +6 more
  • (no location specified)
Apr 22, 2022

NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

Recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Toripalimab
  • +3 more
  • Guanzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Apr 4, 2023

NSCLC Trial (AK119, AK112, Pemetrexed)

Not yet recruiting
  • NSCLC
  • (no location specified)
Nov 23, 2022

Alvopem® (Pemetrexed) Safety Assessment

Completed
  • Non Small Cell Lung Cancer
  • Malignant Pleural Mesothelioma
  • Pemetrexed
  • (no location specified)
Apr 10, 2021

NSCLC Trial in Chalon-sur-Saône, Dijon (Pemetrexed)

Completed
  • Non-small Cell Lung Cancer
  • Pemetrexed
  • Chalon-sur-Saône, France
  • +2 more
May 21, 2021

Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • (no location specified)
Jun 3, 2023

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

Carcinoma, Non-Small Cell Lung Trial in Netherlands (carboplatin, paclitaxel, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
  • +27 more
Dec 6, 2021

Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer Trial (Zimberelimab (ZIM), Domvanalimab (DOM), Sacituzumab

Not yet recruiting
  • Lung Cancer
  • Advanced or Metastatic Non-Small-Cell Lung Cancer
  • Zimberelimab (ZIM)
  • +9 more
  • (no location specified)
Nov 21, 2022